Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
International Journal of Antimicrobial Agents|February 19, 2002
Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756J M Bell, J D Turnidge, R N Jones, et al.The Medical Journal of Australia|October 20, 1979
A survey of cephalosporin use. Monitoring use in a hospital settingS L Arthurson, J D Turnidge, C L OdgersClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
Neurological complications of chlamydial infections: case report and reviewT M Korman, J D Turnidge, M L GraysonAntimicrobial Agents and Chemotherapy|November 26, 2003
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001J M Bell, J D Turnidge, R N Jones, et al.Diagnostic Microbiology and Infectious Disease|May 1, 1996
Disk diffusion interpretive criteria for fusidic acid susceptibility testing of staphylococci by the National Committee for Clinical Laboratory Standards methodC Coutant, D Olden, J Bell, et al.The Journal of Antimicrobial Chemotherapy|July 1, 1994
The postantibiotic effect of antifungal agents against common pathogenic yeastsJ D Turnidge, S Gudmundsson, B Vogelman, et al.Pathology|May 1, 1997
Selection of optimum laboratory tests for the identification of Moraxella catarrhalisS Singh, K M Cisera, J D Turnidge, et al.The Journal of Antimicrobial Chemotherapy|June 25, 1999
The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsisK Leder, J D Turnidge, T M Korman, et al.Antimicrobial Agents and Chemotherapy|June 1, 1996
Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitroP D Midolo, J D Turnidge, J R Lambert, et al.Antimicrobial Agents and Chemotherapy|May 25, 2004
Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001K J Christiansen, J M Bell, J D Turnidge, et al.Pageof 4